Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term immunogenicity and booster kinetics of a new adult tick-borne encephalitis vaccine 5 years after first booster
2005-004459-36Phase 4Completed
- Sponsor
- Chiron Behring Vaccines
- Start
- Nov 2005
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE) (2 arms), sponsored by Chiron Behring Vaccines. Primary endpoints: TBE antibody concentrations by neutralization test, TBE antibody concentrations by ELISA and 2 more. Started Nov 2005; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2005-004459-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004459-36.